Skip to main content
Earnings Labs
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR)

NASDAQ·Healthcare·Biotechnology

$4.43

+3.87%

Mkt Cap $348.12M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (2 analysts)

$10.00

Range $10.00$10.00

Implied Upside

+126.0%

Consensus $10.00 vs current $4.43